Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

This effort, undertaken by Bristol Myers Squibb and agency partner Real Chemistry, is part of the Champions in Care campaign.

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

California healthcare innovator Amgen, which already has facilities at Cambridge Science Park, has made a new and incisive ...

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to ...

Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...

ShipBob, a leading global supply chain and fulfillment platform for SMB and mid-market omnichannel merchants, today announced a major milestone: over one billion units fulfilled across its global ...

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition ageBrigham and Women's Hospital t ...

ProLogium Technology, a leader in solid-state battery R&D and mass production, today announced that it will co-exhibit with FEV Group, a globally leading innovation driver for mobility solutions and ...

This year, the government has decided to include a driver monitoring system in the Korean New Car Assessment Program (KNCAP).

Hatchit Solutions, the Cebu-based technology firm known for building purposeful, impact-driven systems, marks its 10th ...

Friday, January 2, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, ...